Concord Biotech Limited Free Cash Flow Generation Index
Concord Biotech Limited free cash flow generation index. Concord Biotech Limited (CONCORDBIO) has a Free Cash Flow Generation Index of 0.55x as of March 2025. Free cash flow of Rs1.36 Billion represents 1% of operating cash flow (Rs2.47 Billion).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Concord Biotech Limited (2020–2025)
Free cash flow generation index of Concord Biotech Limited from 2020 to 2025. Historical FCF Generation Index trend for Concord Biotech Limited across 6 annual periods. See Concord Biotech Limited (CONCORDBIO) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Concord Biotech Limited Free Cash Flow Generation Index by Year (2020–2025)
Concord Biotech Limited free cash flow generation index by year from 2020 to 2025. Year-by-year Free Cash Flow Generation Index for Concord Biotech Limited. For the full cash flow conversion analysis, see how efficiently does Concord Biotech Limited generate cash.
| Year | FCG Index | Free Cash Flow (INR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.55x | Rs1.36 Billion | Rs2.47 Billion | Rs1.11 Billion | ▼ -18.7% |
| 2024 | 0.68x | Rs1.80 Billion | Rs2.65 Billion | Rs856.88 Million | ▲ +65.1% |
| 2023 | 0.41x | Rs1.01 Billion | Rs2.46 Billion | Rs1.45 Billion | ▲ +63.8% |
| 2022 | 0.25x | Rs519.70 Million | Rs2.07 Billion | Rs1.56 Billion | ▲ +211.8% |
| 2021 | -0.22x | Rs-373.59 Million | Rs1.67 Billion | Rs2.04 Billion | ▼ -5466.2% |
| 2020 | 0.00x | Rs-6.23 Million | Rs1.55 Billion | Rs1.55 Billion | — |